Phase I/II study of biweekly nab‐paclitaxel in patients with platinum‐pretreated non‐small cell lung cancer: NJLCG1402

Phase I/II study of biweekly nab‐paclitaxel in patients with platinum‐pretreated non‐small cell lung cancer: NJLCG1402

Abstract Background NJLCG1402 was a phase I/II trial investigating biweekly nanoparticle albumin‐bound paclitaxel (nab‐PTX) in patients with advanced non‐small cell lung cancer (NSCLC). Methods The study included patients aged ≥20 years with previously treated NSCLC. Nab‐PTX (100–150 mg/m2) was admi...

Full description

Bibliographic Details
Main Authors: Eisaku Miyauchi, Hisashi Tanaka, Atsushi Nakamura, Toshiyuki Harada, Taku Nakagawa, Mami Morita, Daisuke Jingu, Tomoya Kuda, Shunichi Gamou, Ryota Saito, Akira Inoue
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:Thoracic Cancer
Subjects:
nab‐PTX monotherapy
non‐small cell lung cancer
phase I/II trial
Online Access:https://doi.org/10.1111/1759-7714.14149

Internet

https://doi.org/10.1111/1759-7714.14149

Similar Items